IM Cannabis Corp. (IMCC)
3.25
-0.16
(-4.69%)
USD |
NASDAQ |
Aug 31, 14:10
IM Cannabis Net Income (Quarterly) : -3.168M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -3.168M |
| March 31, 2026 | -1.798M |
| December 31, 2025 | -5.641M |
| September 30, 2025 | -2.807M |
| June 30, 2025 | -0.1401M |
| March 31, 2025 | 0.122M |
| December 31, 2024 | -0.8674M |
| September 30, 2024 | -0.7933M |
| June 30, 2024 | -2.526M |
| March 31, 2024 | -4.464M |
| December 31, 2023 | -2.585M |
| September 30, 2023 | -1.593M |
| June 30, 2023 | -2.759M |
| March 31, 2023 | -0.6403M |
| December 31, 2022 | -7.108M |
| September 30, 2022 | -3.470M |
| June 30, 2022 | -2.900M |
| March 31, 2022 | -8.480M |
| December 31, 2021 | -6.632M |
| September 30, 2021 | 0.6589M |
| June 30, 2021 | -4.142M |
| March 31, 2021 | 3.724M |
| December 31, 2020 | -15.33M |
| September 30, 2020 | 0.5537M |
| June 30, 2020 | -6.993M |
| Date | Value |
|---|---|
| March 31, 2020 | 0.1487M |
| January 31, 2020 | |
| October 31, 2019 | |
| July 31, 2019 | |
| April 30, 2019 | -0.0119M |
| January 31, 2019 | -0.0142M |
| October 31, 2018 | -0.0207M |
| July 31, 2018 | -0.0468M |
| April 30, 2018 | -0.0727M |
| January 31, 2018 | -0.0162M |
| October 31, 2017 | -0.0083M |
| July 31, 2017 | -0.0012M |
| April 30, 2017 | |
| January 31, 2017 | |
| October 31, 2016 | |
| July 31, 2016 | |
| April 30, 2016 | |
| January 31, 2016 | |
| October 31, 2015 | |
| July 31, 2015 | |
| April 30, 2015 | 0.0839M |
| January 31, 2015 | -0.0729M |
| October 31, 2014 | -0.0693M |
| July 31, 2014 | -0.0217M |
| April 30, 2014 | -0.0207M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| InterCure Ltd. | -- |
| Teva Pharmaceutical Industries Ltd. | -585.89M |
| RedHill Biopharma Ltd. | -- |
| MediWound Ltd. | -7.392M |
| Purple Biotech Ltd. | 0.4486M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 5.482M |
| Total Expenses (Quarterly) | 8.632M |
| EPS Diluted (Quarterly) | -0.3399 |
| Enterprise Value | 64.05M |
| Gross Profit Margin (Quarterly) | 19.83% |
| Profit Margin (Quarterly) | -57.78% |
| Earnings Yield | -64.42% |
| Normalized Earnings Yield | -64.42 |